MAETZOLD DEREK J sold CSTL
October 19, 2026 · Form 4 insider transaction
MAETZOLD DEREK J sold 2,718 shares of Castle Biosciences, Inc. at $31.91 per share, a transaction worth $86.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2026.; This transaction was executed in multiple trades at prices ranging from $31.67 to $32.53, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.; Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.